Week of February 14th 2022 | Vol. 11, Issue 7
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory
Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
March 21-24, 2022 - New York City, NY
May 17-19, 2022 - Philadelphia, PA
May 24-26, 2022 - New York City, NY
June 13-16, 2022 - San Diego, CA
October 2022 - Charlotte, NC
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS
Pharma & Biotech
6 transactions totaling $3 million

Supplies, Equipment & Services
15 transactions totaling $1,176 million

Healthcare IT & Managed Care
7 transactions totaling $1 million

Healthcare Facilities & Distributors
6 transactions totaling $38 million
PRIVATE PLACEMENTS
Pharma & Biotech
27 transactions totaling $515 million

Supplies, Equipment & Services
20 transactions totaling $925 million

Healthcare IT & Managed Care
21 transactions totaling $329 million

Healthcare Facilities & Distributors
1 transaction
PUBLIC OFFERINGS
Pharma & Biotech
11 transactions totaling $626 million

Supplies, Equipment & Services
8 transactions totaling $64 million

Healthcare IT & Managed Care
2 transactions totaling $47 million

Healthcare Facilities & Distributors
2 transactions totaling $42 million
TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
MARKET REPORTS
Insight Into Healthcare Related Industries
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
Bristol Myers Squibb is earmarking nearly $8 million in new grants to two dozen nonprofits focused on improving access to healthcare in underserved communities.

The latest round of grants is part of the company’s 2020 pledge to donate $150 million over the next five years to organizations focused on reducing health disparities. So far, the company has donated more than $39 million, including the funds announced Tuesday. The grants, which tend to range from one to three years, are aimed at supporting four therapeutic areas: cardiovascular disease, hematology, immunology and oncology.

The Bristol Myers Squibb Foundation has committed an additional $150 million to similar causes, including partnering with National Medical Fellowships to help train 250 new clinical trial investigators, specifically those of color. 
Takeda Ventures has joined Novartis and Merck in backing Koneksa Health, which bills itself as a digital biomarker company. Koneksa's platform stands to benefit from the renewed interest the COVID-19 pandemic brought to remote monitoring of clinical trials.
CooperSurgical has inked an $875 million deal to purchase Cook Medical's reproductive health portfolio, which includes medical devices for fertility, obstetrics, gynecology and in vitro fertilization.
Two U.S. senators introduced bipartisan legislation Monday to extend current Medicare telehealth reimbursement waivers an additional two years following the end of the public health emergency.
Spider-inspired technology isn’t just for comic book characters anymore.  A biomaterial that’s made of silk and takes its construction cues from the strength of spiderwebs has the potential to replace worn-down cartilage around the human knee.

Life-changing treatments might take years to pass necessary regulatory approvals in certain countries, if at all. Tanner enables patient access to innovative medicines through EAPs. Learn more.

The availability of pharmaceuticals can be limited in certain emerging markets around the world. Learn more about how TannerLAC ensures products reach patients in Latin America in this Q&A with Carolina Cortez and Margarita Chala.